For breast cancer, overexpression of CCNE1 have been verified as an early event of breast cancer progression (Shaye et al., 2009), and high level of CCNE1 is often associated with poor prognosis (Fredholm et al., 2017). This evidence concerns the gene CCNE1 and breast carcinoma.